← Back to Search

Other

NT-0796 for Cardiovascular Disease

Phase 1 & 2
Recruiting
Research Sponsored by NodThera Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 28
Awards & highlights

Study Summary

This trial tests a drug to see if it can reduce inflammation in obese people at risk of heart disease. Participants will stay in a hospital for 30 days and get MRI's.

Who is the study for?
This trial is for adults aged 18+ with obesity (BMI between 30 and 40) who are at risk of heart disease due to controlled high blood pressure, cholesterol issues, or diabetes. It's not open to those who've had recent strokes, heart attacks, angina, heart failure, or hepatitis B/C.Check my eligibility
What is being tested?
The study tests NT-0796's effects on inflammation linked to heart disease in obese individuals. It's a randomized test comparing the drug against a placebo while both researchers and participants don't know who gets which treatment. Some will also have MRIs and food impact assessments.See study design
What are the potential side effects?
Potential side effects aren't specified here but typically include reactions at the injection site if applicable, gastrointestinal symptoms like nausea or diarrhea, headaches, dizziness or fatigue. Specifics would be detailed in patient consent forms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to day 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in hsCRP levels
Secondary outcome measures
Body composition
Change in Body weight (kg)
Other outcome measures
Clinical laboratory values
Vital signs

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: NT-0796Experimental Treatment1 Intervention
BID
Group II: PlaceboPlacebo Group1 Intervention
BID

Find a Location

Who is running the clinical trial?

NodThera LimitedLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an open recruitment period for this experiment?

"Affirmative. Clinicaltrials.gov records demonstrate that this clinical trial, initially posted on October 10th 2023 is currently recruiting patients. The research requires 69 individuals from 2 separate medical sites to partake in the experiment."

Answered by AI

To what extent can participants contribute to this trial?

"Affirmative. Clinicaltrials.gov records suggest that this clinical trial, initially published on October 10th 2023, is presently enrolling patients. Approximately 69 individuals need to be registered from 2 different medical centres."

Answered by AI

Who else is applying?

What site did they apply to?
Investigative Site
What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

Unos amigos me dijeron q viajaron de peso y tuvieron una compensacion.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
2023. "Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06129409.
~46 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top